Framework for the determination of yield limits In pharmaceutical operations

Thesis (M. Eng. in Manufacturing)--Massachusetts Institute of Technology, Dept. of Mechanical Engineering, 2010. === Cataloged from PDF version of thesis. === Includes bibliographical references (p. 57). === The manufacturing production of active pharmaceutical ingredients often involve a series of...

Full description

Bibliographic Details
Main Author: Liow, Yuh Han John
Other Authors: Stanley B. Gershwin.
Format: Others
Language:English
Published: Massachusetts Institute of Technology 2011
Subjects:
Online Access:http://hdl.handle.net/1721.1/62672
id ndltd-MIT-oai-dspace.mit.edu-1721.1-62672
record_format oai_dc
spelling ndltd-MIT-oai-dspace.mit.edu-1721.1-626722019-05-02T16:36:58Z Framework for the determination of yield limits In pharmaceutical operations Liow, Yuh Han John Stanley B. Gershwin. Massachusetts Institute of Technology. Dept. of Mechanical Engineering. Massachusetts Institute of Technology. Dept. of Mechanical Engineering. Mechanical Engineering. Thesis (M. Eng. in Manufacturing)--Massachusetts Institute of Technology, Dept. of Mechanical Engineering, 2010. Cataloged from PDF version of thesis. Includes bibliographical references (p. 57). The manufacturing production of active pharmaceutical ingredients often involve a series of processing stages in which yield limits are prescribed to ensure that the target yield has been achieved for a batch and that the workers may proceed to the next batch of materials. Such yield limits is comprised of a maximum value for yields above 100% and a minimum value for yields of lower than 100%. These yield limits for each of the processing steps are conventionally prescribed based on accumulated experiences with production after an extended period of time. This paper is based on an internship project at a major pharmaceutical firm in Singapore, and it discusses the sources of yield losses and the reasons behind yield excursions which have not been well documented within the production facility. In doing so, the paper attempts to provide insights into the possible explanations for the current maximum and minimum yield limits application. Furthermore, using the yield limit values as applied for certain products, a preliminary framework is developed to provide a set of recommendations for the adjustment of conventional yield limit values to suit similar processing stages for the manufacturing of a novel drug product. This framework should prove to be useful in meeting the uncertainties inherent in the production of new products and in making initial recommendations for yield limits since there is usually limited experience from drug developments and clinical manufacture. by Yuh Han John, Liow. M.Eng.in Manufacturing 2011-05-09T15:17:38Z 2011-05-09T15:17:38Z 2010 2010 Thesis http://hdl.handle.net/1721.1/62672 714254959 eng M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582 57 p. application/pdf Massachusetts Institute of Technology
collection NDLTD
language English
format Others
sources NDLTD
topic Mechanical Engineering.
spellingShingle Mechanical Engineering.
Liow, Yuh Han John
Framework for the determination of yield limits In pharmaceutical operations
description Thesis (M. Eng. in Manufacturing)--Massachusetts Institute of Technology, Dept. of Mechanical Engineering, 2010. === Cataloged from PDF version of thesis. === Includes bibliographical references (p. 57). === The manufacturing production of active pharmaceutical ingredients often involve a series of processing stages in which yield limits are prescribed to ensure that the target yield has been achieved for a batch and that the workers may proceed to the next batch of materials. Such yield limits is comprised of a maximum value for yields above 100% and a minimum value for yields of lower than 100%. These yield limits for each of the processing steps are conventionally prescribed based on accumulated experiences with production after an extended period of time. This paper is based on an internship project at a major pharmaceutical firm in Singapore, and it discusses the sources of yield losses and the reasons behind yield excursions which have not been well documented within the production facility. In doing so, the paper attempts to provide insights into the possible explanations for the current maximum and minimum yield limits application. Furthermore, using the yield limit values as applied for certain products, a preliminary framework is developed to provide a set of recommendations for the adjustment of conventional yield limit values to suit similar processing stages for the manufacturing of a novel drug product. This framework should prove to be useful in meeting the uncertainties inherent in the production of new products and in making initial recommendations for yield limits since there is usually limited experience from drug developments and clinical manufacture. === by Yuh Han John, Liow. === M.Eng.in Manufacturing
author2 Stanley B. Gershwin.
author_facet Stanley B. Gershwin.
Liow, Yuh Han John
author Liow, Yuh Han John
author_sort Liow, Yuh Han John
title Framework for the determination of yield limits In pharmaceutical operations
title_short Framework for the determination of yield limits In pharmaceutical operations
title_full Framework for the determination of yield limits In pharmaceutical operations
title_fullStr Framework for the determination of yield limits In pharmaceutical operations
title_full_unstemmed Framework for the determination of yield limits In pharmaceutical operations
title_sort framework for the determination of yield limits in pharmaceutical operations
publisher Massachusetts Institute of Technology
publishDate 2011
url http://hdl.handle.net/1721.1/62672
work_keys_str_mv AT liowyuhhanjohn frameworkforthedeterminationofyieldlimitsinpharmaceuticaloperations
_version_ 1719044027351826432